BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19330187)

  • 1. Massive thyroid involvement by marginal zone B cell NHL as demonstrated by 18F-FDG-PET/CT.
    Bertagna F; Sobic-Saranovic D; Obradovic V; Artiko V; Giubbini R; Alavi A
    Hell J Nucl Med; 2009; 12(1):63. PubMed ID: 19330187
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour thrombus from follicular thyroid cancer detected by 18F-FDG-PET/CT.
    Ozülker T; Ozülker F; Eker O; Ozpaçaci T; Ozcan D
    Hell J Nucl Med; 2009; 12(1):66-7. PubMed ID: 19330189
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
    J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
    Belakhlef A; Jani C; Church C; Fraser R; Lakhanpal S
    Clin Nucl Med; 2008 Apr; 33(4):271-2. PubMed ID: 18356666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
    Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal bone marrow involvement in multicentric castleman disease demonstrated by FDG PET/CT.
    Ramos CD; Massumoto CM; Rosa MF; Mazo-Ruiz MF; Mitteldorf C; Etchebehere EC; Santos AO; Lima MC; Cerri GG; Camargo EE
    Clin Nucl Med; 2007 Apr; 32(4):295-6. PubMed ID: 17413577
    [No Abstract]   [Full Text] [Related]  

  • 9. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
    Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult prolactinoma diagnosed by FDG PET/CT.
    Gemmel F; Balink H; Collins J; Oomen P
    Clin Nucl Med; 2010 Apr; 35(4):269-70. PubMed ID: 20305420
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidental inflammatory findings in nerves and in patients with neoplastic diseases evaluated by 18F-FDG-PET/CT.
    Bertagna F; Giubbini R; Biasiotto G; Rosenbaum J; Alavi A
    Hell J Nucl Med; 2009; 12(3):279-80. PubMed ID: 19936345
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of thyroid plasmacytoma by F-18 FDG PET/CT imaging.
    Ozkan E; Tokmak E; Kir KM
    Clin Nucl Med; 2008 Apr; 33(4):292-3. PubMed ID: 18356675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG-PET/CT in myelofibrosis.
    Behrendt FF; Krohn T; Palmowski M; Mottaghy FM
    Nuklearmedizin; 2011; 50(6):N66-7. PubMed ID: 22138707
    [No Abstract]   [Full Text] [Related]  

  • 15. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
    Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
    Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolapsed endometrial cancer: FDG PET/CT findings.
    Kaneta T; Hakamatsuka T; Yamada T; Sato A; Higano S; Fukuda H; Takahashi S; Yamada S
    Clin Nucl Med; 2006 Mar; 31(3):180. PubMed ID: 16495748
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography-computerized tomography findings in a urinary bladder paraganglioma.
    Thambugala GM; Fulham MJ; Mohamed A
    Australas Radiol; 2007 Oct; 51 Spec No.():B45-7. PubMed ID: 17875156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET-CT findings in epiploic appendagitis.
    Purandare NC; Dua S; Shah S; Gupta K; Sharma AR; Rangarajan V
    Clin Nucl Med; 2009 Dec; 34(12):906-8. PubMed ID: 20139829
    [No Abstract]   [Full Text] [Related]  

  • 19. FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
    Lin EC
    Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous adenocarcinoma of the appendix demonstrated on F-18 FDG PET/CT.
    Lu SJ; Osmany S; Khoo JB; Ng DC
    Clin Nucl Med; 2010 Apr; 35(4):256-7. PubMed ID: 20305414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.